212 related articles for article (PubMed ID: 9630179)
1. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.
Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Vierhapper H; Haas OA; Niederle B
Am J Surg Pathol; 1998 Jun; 22(6):722-8. PubMed ID: 9630179
[TBL] [Abstract][Full Text] [Related]
2. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for reporting C cell pathology of the thyroid.
Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Vierhapper H; Niederle B
Wien Klin Wochenschr; 2002 Apr; 114(7):274-8. PubMed ID: 12089863
[TBL] [Abstract][Full Text] [Related]
4. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N
World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548
[TBL] [Abstract][Full Text] [Related]
5. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
7. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
Weinhaeusel A; Scheuba C; Lauss M; Kriegner A; Kaserer K; Vierlinger K; Haas OA; Niederle B
Thyroid; 2008 Dec; 18(12):1269-76. PubMed ID: 18976163
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.
Marsh DJ; Learoyd DL; Andrew SD; Krishnan L; Pojer R; Richardson AL; Delbridge L; Eng C; Robinson BG
Clin Endocrinol (Oxf); 1996 Mar; 44(3):249-57. PubMed ID: 8729519
[TBL] [Abstract][Full Text] [Related]
9. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
[TBL] [Abstract][Full Text] [Related]
10. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
11. Medullary Thyroid Carcinoma Associated with Germline RET
Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ
Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361
[TBL] [Abstract][Full Text] [Related]
12. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
[TBL] [Abstract][Full Text] [Related]
13. Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers.
Ukkat J; Lorenz K; Hinze R; Thomusch O; Dralle H
World J Surg; 2001 Jun; 25(6):713-7. PubMed ID: 11376404
[TBL] [Abstract][Full Text] [Related]
14. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
16. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
17. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
18. Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.
Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Haas OA; Vierhapper H; Niederle B
Am J Surg Pathol; 2001 Oct; 25(10):1245-51. PubMed ID: 11688458
[TBL] [Abstract][Full Text] [Related]
19. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
